| Product Code: ETC7549558 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Onychomycosis Drug Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Onychomycosis Drug Market Revenues & Volume, 2021 & 2031F |
3.3 India Onychomycosis Drug Market - Industry Life Cycle |
3.4 India Onychomycosis Drug Market - Porter's Five Forces |
3.5 India Onychomycosis Drug Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 India Onychomycosis Drug Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 India Onychomycosis Drug Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 India Onychomycosis Drug Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 India Onychomycosis Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 India Onychomycosis Drug Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 India Onychomycosis Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of onychomycosis in India |
4.2.2 Rising awareness about the importance of treating onychomycosis |
4.2.3 Technological advancements in drug delivery systems for onychomycosis treatment |
4.3 Market Restraints |
4.3.1 High cost associated with onychomycosis drug treatments |
4.3.2 Limited availability of specialized healthcare professionals for onychomycosis diagnosis and treatment |
4.3.3 Stringent regulatory requirements for drug approval in India |
5 India Onychomycosis Drug Market Trends |
6 India Onychomycosis Drug Market, By Types |
6.1 India Onychomycosis Drug Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 India Onychomycosis Drug Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 India Onychomycosis Drug Market Revenues & Volume, By Proximal Subungual, 2021- 2031F |
6.1.4 India Onychomycosis Drug Market Revenues & Volume, By Distal Subungual, 2021- 2031F |
6.1.5 India Onychomycosis Drug Market Revenues & Volume, By Candidal, 2021- 2031F |
6.1.6 India Onychomycosis Drug Market Revenues & Volume, By White Superficial, 2021- 2031F |
6.1.7 India Onychomycosis Drug Market Revenues & Volume, By Total Dystrophic, 2021- 2031F |
6.2 India Onychomycosis Drug Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 India Onychomycosis Drug Market Revenues & Volume, By Griseofulvin, 2021- 2031F |
6.2.3 India Onychomycosis Drug Market Revenues & Volume, By Ketoconazole, 2021- 2031F |
6.2.4 India Onychomycosis Drug Market Revenues & Volume, By Ciclopirox, 2021- 2031F |
6.2.5 India Onychomycosis Drug Market Revenues & Volume, By Terbinafine, 2021- 2031F |
6.2.6 India Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Onychomycosis Drug Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 India Onychomycosis Drug Market Revenues & Volume, By Medication, 2021- 2031F |
6.3.3 India Onychomycosis Drug Market Revenues & Volume, By Topical Therapy, 2021- 2031F |
6.3.4 India Onychomycosis Drug Market Revenues & Volume, By Debridement, 2021- 2031F |
6.4 India Onychomycosis Drug Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 India Onychomycosis Drug Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 India Onychomycosis Drug Market Revenues & Volume, By Topical, 2021- 2031F |
6.4.4 India Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Onychomycosis Drug Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Onychomycosis Drug Market Revenues & Volume, By Direct, 2021- 2031F |
6.5.3 India Onychomycosis Drug Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Onychomycosis Drug Market Revenues & Volume, By Retailers and, 2021- 2031F |
6.5.5 India Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
6.6 India Onychomycosis Drug Market, By End Users |
6.6.1 Overview and Analysis |
6.6.2 India Onychomycosis Drug Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 India Onychomycosis Drug Market Revenues & Volume, By Homecare, 2021- 2031F |
6.6.4 India Onychomycosis Drug Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.5 India Onychomycosis Drug Market Revenues & Volume, By Others, 2021- 2031F |
7 India Onychomycosis Drug Market Import-Export Trade Statistics |
7.1 India Onychomycosis Drug Market Export to Major Countries |
7.2 India Onychomycosis Drug Market Imports from Major Countries |
8 India Onychomycosis Drug Market Key Performance Indicators |
8.1 Average time taken for onychomycosis diagnosis and treatment |
8.2 Patient adherence rate to prescribed onychomycosis drug therapies |
8.3 Number of research and development collaborations for innovative onychomycosis treatments |
9 India Onychomycosis Drug Market - Opportunity Assessment |
9.1 India Onychomycosis Drug Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 India Onychomycosis Drug Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 India Onychomycosis Drug Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 India Onychomycosis Drug Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 India Onychomycosis Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 India Onychomycosis Drug Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 India Onychomycosis Drug Market - Competitive Landscape |
10.1 India Onychomycosis Drug Market Revenue Share, By Companies, 2024 |
10.2 India Onychomycosis Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here